Alkermes (ALKS) Sales of Property, Plant and Equipment (2010 - 2026)
Powered by 
Analysis
Alkermes (ALKS) Sales of Property, Plant and Equipment (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Sales of Property, Plant and Equipment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.56 Bn | 624.80 Bn | 17.26 Bn | 63.00 Mn |
| 2 | AbbVie | 443.23 Bn | 436.66 Bn | 12.70 Bn | - |
| 3 | Merck | 365.57 Bn | 358.43 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.52 Bn | 258.83 Bn | 11.24 Bn | 26.00 Mn |
| 5 | Pfizer | 158.43 Bn | 146.73 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 363.82 Mn |
| 7 | Revolution Medicines | 43.87 Bn | 43.87 Bn | - | - |
| 8 | Incyte | 25.35 Bn | 20.81 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.56 Bn | 18.89 Bn | 683.80 Mn | - |
| 10 | Alkermes | 7.58 Bn | 6.92 Bn | 397.90 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 1.05 Mn |
| Jun 30, 2025 | -1.68 Mn |
| Mar 31, 2025 | 1.71 Mn |
| Dec 31, 2024 | 7,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 23,000.00 |
| Mar 31, 2024 | 411,000.00 |
| Dec 31, 2023 | 348,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 176,000.00 |
| Dec 31, 2020 | 582,000.00 |
| Sep 30, 2020 | 56,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Mar 31, 2020 | 3,000.00 |
| Sep 30, 2019 | 609,000.00 |
| Jun 30, 2019 | 206,000.00 |